A new divergent synthesis of (+)- and (-)-ferruginine utilizing PLE-catalyzed asymmetric dealkoxycarbonylation

Tetrahedron Asymmetry

Volumn 13, Issue 21, 2002, Pages 2351-2358

  Katoh, Takahiro ^a   Kakiya, Kiyoshi ^a   Nakai, Takashi ^a   Nakamura, Soichi ^a   Nishide, Kiyoharu ^a   Node, Manabu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; DIETHYL 8 BENZYL 3 OXO 8 AZABICYCLO[3.2.1]OCTAN 2,4 DICARBOXYLATE; ESTER DERIVATIVE; ETHYL 8 BENZYL 3 OXO 8 AZABICYCLO[3.2.1]OCTAN 2 CARBOXYLATE; FERRUGININE; METHYL 8 BENZYL 3 OXO 8 AZABICYCLO[3.2.1]OCTAN 2 CARBOXYLATE; UNCLASSIFIED DRUG;

ARTICLE; CATALYST; CHEMICAL REACTION; DEALKOXYCARBONYLATION; DRUG SYNTHESIS; ENANTIOMER; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 0037206738     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0957-4166(02)00657-2     Document Type: Article

References (32)

1. For examples, see: (a) Clarke, R. L.; Daum, S. J.; Gambino, A. J.; Aceto, M. D.; Pearl, J.; Levitt, M.; Cumiskey, W. R.; Bogado, E. F. J. Med. Chem. 1973, 16, 1260-1267; (b) Carroll, F. I.; Gao, Y.; Rahman, M. A.; Abraham, P.; Parham, K.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. J. Med. Chem. 1991, 34, 2719-2725; (c) Wang, S.; Gao, Y.; Laruelle, M.; Baldwin, R. M.; Scanley, B. E.; Innis, R. B.; Neumeyer, J. L. J. Med. Chem. 1993, 36, 1914-1917; (d) Meltzer, P. C.; Liang, A. Y.; Madras, B. K. J. Med. Chem. 1994, 37, 2001-2010.
2. For examples, see: (a) Clarke, R. L.; Daum, S. J.; Gambino, A. J.; Aceto, M. D.; Pearl, J.; Levitt, M.; Cumiskey, W. R.; Bogado, E. F. J. Med. Chem. 1973, 16, 1260-1267; (b) Carroll, F. I.; Gao, Y.; Rahman, M. A.; Abraham, P.; Parham, K.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. J. Med. Chem. 1991, 34, 2719-2725; (c) Wang, S.; Gao, Y.; Laruelle, M.; Baldwin, R. M.; Scanley, B. E.; Innis, R. B.; Neumeyer, J. L. J. Med. Chem. 1993, 36, 1914-1917; (d) Meltzer, P. C.; Liang, A. Y.; Madras, B. K. J. Med. Chem. 1994, 37, 2001-2010.
3. For examples, see: (a) Clarke, R. L.; Daum, S. J.; Gambino, A. J.; Aceto, M. D.; Pearl, J.; Levitt, M.; Cumiskey, W. R.; Bogado, E. F. J. Med. Chem. 1973, 16, 1260-1267; (b) Carroll, F. I.; Gao, Y.; Rahman, M. A.; Abraham, P.; Parham, K.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. J. Med. Chem. 1991, 34, 2719-2725; (c) Wang, S.; Gao, Y.; Laruelle, M.; Baldwin, R. M.; Scanley, B. E.; Innis, R. B.; Neumeyer, J. L. J. Med. Chem. 1993, 36, 1914-1917; (d) Meltzer, P. C.; Liang, A. Y.; Madras, B. K. J. Med. Chem. 1994, 37, 2001-2010.
4. For examples, see: (a) Clarke, R. L.; Daum, S. J.; Gambino, A. J.; Aceto, M. D.; Pearl, J.; Levitt, M.; Cumiskey, W. R.; Bogado, E. F. J. Med. Chem. 1973, 16, 1260-1267; (b) Carroll, F. I.; Gao, Y.; Rahman, M. A.; Abraham, P.; Parham, K.; Lewin, A. H.; Boja, J. W.; Kuhar, M. J. J. Med. Chem. 1991, 34, 2719-2725; (c) Wang, S.; Gao, Y.; Laruelle, M.; Baldwin, R. M.; Scanley, B. E.; Innis, R. B.; Neumeyer, J. L. J. Med. Chem. 1993, 36, 1914-1917; (d) Meltzer, P. C.; Liang, A. Y.; Madras, B. K. J. Med. Chem. 1994, 37, 2001-2010.
5. For examples, see: (a) Canfield, D. R.; Spealman, R. D.; Kaufman, M. J.; Madras, B. K. Synapse 1990, 6, 189-195; (b) Kaufman, M. J.; Madras, B. K. Synapse 1991, 9, 43-49.
6. For examples, see: (a) Canfield, D. R.; Spealman, R. D.; Kaufman, M. J.; Madras, B. K. Synapse 1990, 6, 189-195; (b) Kaufman, M. J.; Madras, B. K. Synapse 1991, 9, 43-49.
7. . For a synthesis of (±)-2, see: Davies H.M.L., Saikali E., Young W.B. J. Org. Chem. 56:1991;5696-5700.
8. . For a synthesis of (+)-2, see: Majewski M., Lazny R. J. Org. Chem. 60:1995;5825-5830.
9. Zirkle C.L., Geissman T.A., Bloom M., Craig P.N., Gerns F.R., Indik Z.K., Pavloff A.M. J. Org. Chem. 27:1962;1269-1279.
10. Campbell H.F., Edwards O.E., Kolt R. Can. J. Chem. 55:1977;1372-1379.
11. Milius R.A., Saha J.K., Madras B.K., Neumeyer J.L. J. Med. Chem. 34:1991;1728-1731.
12. Kozikowski A.P., Saiah M.K.E., Johnson K.M., Bergmann J.S. J. Med. Chem. 38:1995;3086-3093.
13. Keverline K.I., Abraham P., Lewin A.H., Carroll F.I. Tetrahedron Lett. 36:1995;3099-3102.
14. Node M., Nakamura S., Nakamura D., Katoh T., Nishide K. Tetrahedron Lett. 40:1999;5357-5360.
15. For lipase-catalyzed demethoxycarbonylation and applications, see: (a) Node, M.; Inoue, T.; Araki, M.; Nakamura, D.; Nishide, K. Tetrahedron Lett. 1995, 36, 2255-2256; (b) Node, M.; Nakamura, D.; Nishide, K.; Inoue, T. Heterocycles 1997, 46, 535-540; (c) Node, M.; Inoue, T.; Araki, M.; Nakamura, D.; Nishide, K. Tetrahedron: Asymmetry 1998, 9, 157-167; (d) Node, M.; Araki, M.; Tanaka, H.; Nakamura, D.; Inoue, T.; Nishide, K. Chem. Pharm. Bull. 1998, 46, 736-738.
16. For lipase-catalyzed demethoxycarbonylation and applications, see: (a) Node, M.; Inoue, T.; Araki, M.; Nakamura, D.; Nishide, K. Tetrahedron Lett. 1995, 36, 2255-2256; (b) Node, M.; Nakamura, D.; Nishide, K.; Inoue, T. Heterocycles 1997, 46, 535-540; (c) Node, M.; Inoue, T.; Araki, M.; Nakamura, D.; Nishide, K. Tetrahedron: Asymmetry 1998, 9, 157-167; (d) Node, M.; Araki, M.; Tanaka, H.; Nakamura, D.; Inoue, T.; Nishide, K. Chem. Pharm. Bull. 1998, 46, 736-738.
17. For lipase-catalyzed demethoxycarbonylation and applications, see: (a) Node, M.; Inoue, T.; Araki, M.; Nakamura, D.; Nishide, K. Tetrahedron Lett. 1995, 36, 2255-2256; (b) Node, M.; Nakamura, D.; Nishide, K.; Inoue, T. Heterocycles 1997, 46, 535-540; (c) Node, M.; Inoue, T.; Araki, M.; Nakamura, D.; Nishide, K. Tetrahedron: Asymmetry 1998, 9, 157-167; (d) Node, M.; Araki, M.; Tanaka, H.; Nakamura, D.; Inoue, T.; Nishide, K. Chem. Pharm. Bull. 1998, 46, 736-738.
18. For lipase-catalyzed demethoxycarbonylation and applications, see: (a) Node, M.; Inoue, T.; Araki, M.; Nakamura, D.; Nishide, K. Tetrahedron Lett. 1995, 36, 2255-2256; (b) Node, M.; Nakamura, D.; Nishide, K.; Inoue, T. Heterocycles 1997, 46, 535-540; (c) Node, M.; Inoue, T.; Araki, M.; Nakamura, D.; Nishide, K. Tetrahedron: Asymmetry 1998, 9, 157-167; (d) Node, M.; Araki, M.; Tanaka, H.; Nakamura, D.; Inoue, T.; Nishide, K. Chem. Pharm. Bull. 1998, 46, 736-738.
19. Bick I.R.C., Gillard J.W., Leow H.-M. Aust. J. Chem. 32:1979;2537-2543.
20. Bick I.R.C., Gillard J.W., Leow H.-M. Aust. J. Chem. 32:1979;2523-2536.
21. Swanson, K. L.; Albuquerque, E. X. Handbook of Experimental Pharmacology, Vol. 102. Selective Neurotoxicity; Herken, H.; Hucho, F., Eds.; Springer: Berlin, 1992; pp. 620-621.
22. For example, see: (a) Gündisch, D.; Harms, K.; Schewarz, S.; Seitz, G.; Stubbs, M. T.; Wegge, T. Bioorg. Med. Chem. 2001, 9, 2683-2691; (b) Gündisch, D.; Kämpchen, T.; Schewarz, S.; Seitz, G.; Siegl, J.; Wegge, T. Bioorg. Med. Chem. 2002, 10, 1-9.
23. For example, see: (a) Gündisch, D.; Harms, K.; Schewarz, S.; Seitz, G.; Stubbs, M. T.; Wegge, T. Bioorg. Med. Chem. 2001, 9, 2683-2691; (b) Gündisch, D.; Kämpchen, T.; Schewarz, S.; Seitz, G.; Siegl, J.; Wegge, T. Bioorg. Med. Chem. 2002, 10, 1-9.
24. Davies H.M.L., Matasi J.J., Hodges L.M., Huby N.J.S., Thornley C., Kong N., Houser J.H. J. Org. Chem. 62:1997;1095-1105.
25. Hernández A.S., Thaler A.T., Castells J., Rapoport H. J. Org. Chem. 61:1996;314-323.
26. Gauthier I., Royer J., Husson H.-P. J. Org. Chem. 62:1997;6704-6705.
27. Gillaizeau-Gauthier I., Royer J., Husson H.-P. Eur. J. Org. Chem. 2002;1484-1489.
28. Rigby J.H., Pigge F.C. J. Org. Chem. 60:1995;7392-7393.
29. Robinson R. J. Chem. Soc. 111:1917;762-768.
30. Majewski M., Lazny R. J. Org. Chem. 60:1995;5825-5830.
31. 1H COSY NMR, but the configuration of the alcoholic carbon was unknown. However, it was not necessary to determine the configuration at this centre due to the oxidation of the hydroxyl group in a subsequent step.
32. Cacchi S., Ciattini P.G., Morera E., Ortar G. Tetrahedron Lett. 27:1986;5541-5555.